Articles les plus consultés

jeudi 26 avril 2018

Aquinox to Present at 2018 Bloom Burton & Co. Healthcare Conference

Aquinox to Present at 2018 Bloom Burton & Co. Healthcare Conference

GlycoMimetics to Report First Quarter 2018 Financial Results on May 3, 2018 | Business Wire

GlycoMimetics to Report First Quarter 2018 Financial Results on May 3, 2018 | Business Wire: GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that it will host a conference call and webcast to report its first quarter 2018 financial results

Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006, in Patients with Advanced Cancer

Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006, in Patients with Advanced Cancer: Three-arm Trial Will Evaluate CPI-006 as Monotherapy, in Combination with CPI-444 Adenosine Antagonist and in Combination with Pembrolizumab

Imagin Gains Momentum; Positive Progress in Research Study

Imagin Gains Momentum; Positive Progress in Research Study

CGG: announces issuance of $300 million and €280 million First Lien Senior Secured Notes

CGG: announces issuance of $300 million and €280 million First Lien Senior Secured Notes

Corbus Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference

Corbus Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference: Live audio presentation and webcast on Wednesday, May 9th at 11:20 a.m. EDT

CrownBio Launches New Humanized Target Model for Immunotherapy

CrownBio Launches New Humanized Target Model for Immunotherapy

Aerie Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018 | Business Wire

Aerie Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018 | Business Wire: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), announced today that its first quarter 2018 financial results will be released after

Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study | Business Wire

Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study | Business Wire: Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study

Agence européenne des médicaments - Trouver des médicaments - Stribild

Agence européenne des médicaments - Trouver des médicaments - Stribild: Agence européenne des médicaments - Trouver des médicaments - Stribild

Amarin To Report First Quarter 2018 Results and Host Conference Call On May 2, 2018

Amarin To Report First Quarter 2018 Results and Host Conference Call On May 2, 2018

Innovus Pharma Announces the Launch of its Hemorrhoid Drug Xyralid® in Canada | Business Wire

Innovus Pharma Announces the Launch of its Hemorrhoid Drug Xyralid® in Canada | Business Wire: Innovus Pharmaceuticals, Inc. (

UMICORE

La tendance est haussière

Stratégie du 26/04/2018 | 10:09
ACHAT
En cours
Cours d'entrée : 42.77€ | Objectif : 46€ | Stop : 41.1€ | Potentiel : 7.55%
La valeur Umicore présente une configuration technique positive qui suggère de prendre le train de la hausse.
On pourra se positionner à l'achat pour viser les 46 €.

BONJOUR......EUROPACOR



Europacorp est toujours entourée $ECP Prise d'appui sur 2.80€ ce matin, résistance à 3.05€ et 3.15€ .
..HIER LE 24/04/2018

mercredi 25 avril 2018

plus haut/plus bas

Lors de la séance du mercredi 25 avril 2018 les actions ou indices suivants ont attteint leur plus haut niveau de valorisation sur une période 1 an
Agta Record  (66,50)
Quadpack Industries  (25,20)
Crcam Touraine Cci  (106,02)
Lvmh  (285,85)
Locindus  (21,90)
Kering  (470,80)
Colas  (192,00)
Dassault Aviation  (1708,00)
Aufeminin  (38,80)
Voyageurs du monde  (125,50)
Microwave Vision  (11,90)
Part.Indles Mini.  (10,40)
Cegereal  (42,20)
Prodware  (13,88)
Weborama  (14,90)
Miguet et Associes Regr.  (0,92)
Multimicrocloud  (1,06)

Lors de la séance du mercredi 25 avril 2018 les actions ou indices suivants ont attteint leur plus bas niveau de valorisation sur une période 1 an
BRL-EUR  (0,234)
BRL-USD  (0,285)
INR-USD  (0,015)
Vilmorin Cie  (56,40)
St Dupont  (0,144)
M.R.M  (1,69)
Marie Brizard Wine and Spirits  (7,66)
Neovacs  (0,361)
Nextedia  (0,97)
Tarkett  (21,38)
Theraclion  (3,33)
Trilogiq  (6,60)
Integragen  (2,13)
Biosynex  (2,97)
Patrimoine et Commerce  (19,20)
Smalto  (0,05)
Global Ecopower  (2,31)
Sequana  (0,565)
Ekinops  (3,46)
Mnd  (3,50)
Neolife  (0,345)
Sergeferrari Group  (10,00)
Orchestra-Premaman  (2,49)
Stallergenes Greer  (24,05)

Retrouvez sur cett

ANTI-VIRUS

Si vous avez des doutes sur le fait que votre antivirus soit actif, il vous suffit de télécharger le fichier suivant

Avivagen Announces OxC-beta™ Purchase Order with New Customer

Avivagen Announces OxC-beta™ Purchase Order with New Customer

PDG Juno et co-fondateur démissionne à la suite de l'acquisition de Celgene | Pharmafile

PDG Juno et co-fondateur démissionne à la suite de l'acquisition de Celgene | Pharmafile

Kallelse till årsstämma i Xbrane Biopharma AB

Kallelse till årsstämma i Xbrane Biopharma AB